ALFA Finder
19:08 IST
NSE
Results Update
Supriya Lifescience Results Update
Supriya Lifescience's Q2 FY27 revenue rose 3.2%, but EBITDA and PAT fell sharply. Ambernath ramp-up costs and LATAM regulatory shifts hurt margins.
Supriya Lifescience Ltd
- Share price
- ₹637.90
- Market cap
- ₹5,134 Cr
- Revenue (annual)
- ₹827.9 Cr
- Net profit (annual)
- ₹209.1 Cr
- P/E (TTM)
- 29.0×Sector 43.8×
- Promoter holding
- 68.30%+0.00% QoQ
- FII holding
- 6.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 6Earnings Call 5Annual General Meeting 5Other Announcement 4Financial Results 4Results Update 3Board Meeting Date 3Dividend 2Results Correction 1Regulatory Approval 1Debt & Borrowing 1
Time
3 announcements with these filters
23:27 IST
NSE
Results Update
Supriya Lifescience Results Update
Supriya Lifescience announced financial highlights for Q1 FY27, reporting revenue of Rs. 189.75 crore and profit after tax of Rs. 24.04 crore for the quarter.
09:13 IST
NSE
Results Update
Supriya Lifescience Results Update
Supriya Lifescience reported FY26 revenue of ₹827.87 Crore, up 18.9% YoY. Strong Q4 performance and capacity expansion signal robust growth across key therapeutic segments.
- Value
- ₹827.9 Cr